These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14577954)

  • 21. High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies.
    Collot M; Rouard C; Brunet C; Agut H; Boutolleau D; Burrel S
    Antiviral Res; 2016 Apr; 128():1-6. PubMed ID: 26826441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture.
    Biswas S; Jennens L; Field HJ
    Arch Virol; 2007; 152(8):1489-500. PubMed ID: 17404685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.
    Betz UA; Fischer R; Kleymann G; Hendrix M; Rübsamen-Waigmann H
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1766-72. PubMed ID: 12019088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease.
    Baumeister J; Fischer R; Eckenberg P; Henninger K; Ruebsamen-Waigmann H; Kleymann G
    Antivir Chem Chemother; 2007; 18(1):35-48. PubMed ID: 17354650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
    Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
    Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of herpes simplex virus isolated from genital herpes lesions to ASP2151, a novel helicase-primase inhibitor.
    Katsumata K; Weinberg A; Chono K; Takakura S; Kontani T; Suzuki H
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3587-91. PubMed ID: 22526302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster.
    Shiraki K; Yasumoto S; Toyama N; Fukuda H
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster.
    Shiraki K
    Drugs Today (Barc); 2017 Nov; 53(11):573-584. PubMed ID: 29451274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicases as antiviral drug targets.
    Frick DN
    Drug News Perspect; 2003; 16(6):355-62. PubMed ID: 12973446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicase-primase inhibitors from Medshine Discovery Inc. (WO2018/127207 and WO2020/007355) for the treatment of herpes simplex virus infections - structure proposal for Phaeno Therapeutics drug candidate HN0037.
    Gege C; Kleymann G
    Expert Opin Ther Pat; 2022 Sep; 32(9):933-937. PubMed ID: 35965439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-nucleoside inhibitors of herpesviruses.
    Wathen MW
    Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities and challenges.
    Griffiths PD
    Herpes; 2003 Aug; 10(2):31. PubMed ID: 14577951
    [No Abstract]   [Full Text] [Related]  

  • 33. High-throughput screening assay for helicase enzymes.
    Sivaraja M; Giordano H; Peterson MG
    Anal Biochem; 1998 Dec; 265(1):22-7. PubMed ID: 9866703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection.
    Katsumata K; Chono K; Suzuki H
    Biochem Pharmacol; 2018 Dec; 158():201-206. PubMed ID: 30365949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral Drugs Against Alphaherpesvirus.
    Shiraki K
    Adv Exp Med Biol; 2018; 1045():103-122. PubMed ID: 29896665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A short commentary on the review by Weller and Kuchta: the DNA helicase-primase complex as a target for herpes virus infection.
    Field HJ
    Expert Opin Ther Targets; 2013 Oct; 17(10):1113-4. PubMed ID: 24044544
    [No Abstract]   [Full Text] [Related]  

  • 37. Antivirals against DNA viruses (hepatitis B and the herpes viruses).
    Hewlett G; Hallenberger S; Rübsamen-Waigmann H
    Curr Opin Pharmacol; 2004 Oct; 4(5):453-64. PubMed ID: 15351349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections.
    Enright AM; Prober C
    Herpes; 2003 Aug; 10(2):32-7. PubMed ID: 14577952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection.
    Katsumata K; Chono K; Kato K; Ohtsu Y; Takakura S; Kontani T; Suzuki H
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1339-46. PubMed ID: 23274658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes simplex virus infections in preterm infants.
    O'Riordan DP; Golden WC; Aucott SW
    Pediatrics; 2006 Dec; 118(6):e1612-20. PubMed ID: 17142491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.